FDA Expands Drug Center Leadership With Temple, Throckmorton Promotions
This article was originally published in The Tan Sheet
Executive Summary
The elevation of FDA's Bob Temple and Douglas Throckmorton to deputy director positions in the agency's drug center expands the top-level leadership team at the center